Envestnet Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-9,159
| Closed | -$273K | – | 4438 |
|
2024
Q4 | $273K | Buy |
+9,159
| New | +$273K | ﹤0.01% | 3939 |
|
2023
Q4 | – | Sell |
-12,515
| Closed | -$202K | – | 4127 |
|
2023
Q3 | $202K | Buy |
12,515
+1,834
| +17% | +$29.6K | ﹤0.01% | 3740 |
|
2023
Q2 | $443K | Sell |
10,681
-69,497
| -87% | -$2.88M | ﹤0.01% | 3280 |
|
2023
Q1 | $620K | Buy |
80,178
+56,090
| +233% | +$434K | ﹤0.01% | 3006 |
|
2022
Q4 | $1.77M | Buy |
24,088
+2,755
| +13% | +$202K | ﹤0.01% | 2247 |
|
2022
Q3 | $1.62M | Sell |
21,333
-279
| -1% | -$21.2K | ﹤0.01% | 2209 |
|
2022
Q2 | $1.5M | Sell |
21,612
-3,518
| -14% | -$244K | ﹤0.01% | 2296 |
|
2022
Q1 | $2.08M | Sell |
25,130
-1,745
| -6% | -$145K | ﹤0.01% | 2172 |
|
2021
Q4 | $2.02M | Buy |
26,875
+824
| +3% | +$61.9K | ﹤0.01% | 2173 |
|
2021
Q3 | $3.03M | Buy |
26,051
+7,161
| +38% | +$832K | ﹤0.01% | 1831 |
|
2021
Q2 | $4.19M | Buy |
18,890
+2,840
| +18% | +$630K | ﹤0.01% | 1627 |
|
2021
Q1 | $2.12M | Sell |
16,050
-295
| -2% | -$39K | ﹤0.01% | 1901 |
|
2020
Q4 | $2.83M | Buy |
16,345
+390
| +2% | +$67.5K | ﹤0.01% | 1556 |
|
2020
Q3 | $1.78M | Sell |
15,955
-1,170
| -7% | -$130K | ﹤0.01% | 1687 |
|
2020
Q2 | $1.02M | Buy |
17,125
+1,530
| +10% | +$90.8K | ﹤0.01% | 1961 |
|
2020
Q1 | $1.05M | Buy |
15,595
+2,872
| +23% | +$193K | ﹤0.01% | 1787 |
|
2019
Q4 | $1.07M | Buy |
12,723
+1,380
| +12% | +$116K | ﹤0.01% | 1982 |
|
2019
Q3 | $848K | Sell |
11,343
-1,019
| -8% | -$76.2K | ﹤0.01% | 2054 |
|
2019
Q2 | $782K | Buy |
12,362
+697
| +6% | +$44.1K | ﹤0.01% | 2109 |
|
2019
Q1 | $562K | Sell |
11,665
-347
| -3% | -$16.7K | ﹤0.01% | 2277 |
|
2018
Q4 | $402K | Buy |
+12,012
| New | +$402K | ﹤0.01% | 2275 |
|
2018
Q3 | – | Sell |
-4,324
| Closed | -$135K | – | 2149 |
|
2018
Q2 | $135K | Buy |
+4,324
| New | +$135K | ﹤0.01% | 1875 |
|